Foundation Medicine (FMI) Misses Q4 EPS by 9c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus
Note: EPS may not be comparable
Foundation Medicine (NASDAQ: FMI) reported Q4 EPS of ($1.05), $0.09 worse than the analyst estimate of ($0.96). Revenue for the quarter came in at $48.9 million versus the consensus estimate of $46.21 million.
Foundation Medicine sees FY2018 revenue of $200-220 million, versus the consensus of $194.82 million.
For earnings history and earnings-related data on Foundation Medicine (FMI) click here.